Risk Assessment of Linezolid-Associated Neurological Adverse Drug Reactions Based on the Food and Drug Administration Adverse Event Reporting System Database
This study highlights the need for careful monitoring of neurological ADRs associated with linezolid, vigilance regarding previously undocumented ADRs and the prudent management of concomitant medications. These findings provide essential guidance for the safe clinical use of linezolid.
Authors
- Kunkun Wang (ORCID: https://orcid.org/0000-0002-5916-0311)
- Xi Chen
- Yu Wang (ORCID: https://orcid.org/0000-0003-4505-1816)
- Jingjing Sun (ORCID: https://orcid.org/0000-0002-3181-3966)
- Jingwen Yin (ORCID: https://orcid.org/0000-0003-2914-2136)
Institutions
- Tianjin People's Hospital (CN)
Publication Details
- Journal
- Journal of Multidisciplinary Healthcare
- Published
- 2025-05-01
- DOI
- https://doi.org/10.2147/jmdh.s507827
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31